A Randomized Trial of Paracentesis plus Intraperitoneal Tumor Necrosis Factor- versus Paracentesis Alone in Patients with Symptomatic Ascites from Recurrent Ovarian Carcinoma

Author： Hirte H.W.   Miller D.   Tonkin K.   Findlay B.   Capstick V.   Murphy J.   Buckman R.   Carmichael J.   Levine M.   Hill W.  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.64, Iss.1, 1997-01, pp. : 80-87

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraperitoneal Pressures and Clinical Parameters of Total Paracentesis for Palliation of Symptomatic Ascites in Ovarian Cancer

By Gotlieb W.H.   Feldman B.   Feldman-Moran O.   Zmira N.   Kreizer D.   Segal Y.   Elran E.   Ben-Baruch G.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 381-385

Elsevier

Access to resources Recommend Favorite

The Ability of Existing Questionnaires to Measure Symptom Change After Paracentesis for Symptomatic Ascites

By Easson Alexandra   Bezjak Andrea   Ross Susan   Wright Jim  

Annals of Surgical Oncology, Vol. 14, Iss. 8, 2007-08 ,pp. : 2348-2357

Springer Publishing Company

Access to resources Recommend Favorite

Randomized Phase II Trial of Thalidomide Alone versus Thalidomide Plus Interferon Alpha in Patients with Refractory Multiple Myeloma

By Chiou Tzeon-Jye   Wang Teng-Hsu   Chao Tsu-Yi   Lin Sheng-Fung   Tang Jih-Luh   Chen Tsai-Yun   Chang Ming-Chih   Hsueh Erh-Jung   Chen Po-Min  

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 140-147

Informa Healthcare

Access to resources Recommend Favorite

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

By Clemons Mark   Joy Anil   Abdulnabi Radhi   Kotliar Mauricio   Lynch Jodi   Jordaan Johan   Iscoe Neill   Gelmon Karen  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Multicenter, randomized trial of ramosetron plus dexamethasone versus ramosetron alone in controlling cisplatin-induced emesis

By Villalon Antonio  

Supportive Care in Cancer, Vol. 12, Iss. 1, 2004-01 ,pp. : 58-63

Springer Publishing Company

Access to resources Recommend Favorite